Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva's new launches won't feel the sting of hefty cost cuts: CEO
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Submitted by
admin
on December 18, 2017 - 11:25am
Source:
Fierce Pharma
News Tags:
Teva Pharmaceutical
drug launches
Pharma CEOs
Kåre Schultz
layoffs
Austedo
fremanezumab
Headline:
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Do Not Allow Advertisers to Use My Personal information
